Hepatitis
The Pharmacy Times® Hepatitis resource center provides clinical news and articles, pertaining to the Food and Drug Administration approved therapies to treat Hepatitis A, B, and C. Additionally, pharmacists will find coverage from pertinent conferences and meetings, videos, podcasts, and other associated content.
What can we help you find?
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_3.42.32_PM.png)
Experts in the management of hepatitis C provide an understanding for when to screen annually and why pregnant women should be screened.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_2.25.01_PM.png)
A review of the current screening recommendations for hepatitis C by experts in the field of hepatitis C.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_11.49.43_AM.png)
The panel of experts in hepatitis C continue to discuss the development of hepatocellcular carcinoma in untreated patients.
Experts in the management of hepatitis C identify some of the complications of the disease, particularly cirrhosis and decompensated cirrhosis.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_11.15.39_AM.png)
An introduction to diagnosing hepatitis C and understanding the difference between a positive antibody test and positive viral load
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_11.12.33_AM.png)
Caroline Derrick, PharmD, BCPS, provides an understanding of the pathophysiology of hepatitis C and shares some common symptoms.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2020-02-28_Screen_Shot_2020-02-28_at_11.08.18_AM.png)
Christopher Hulstein, PharmD, BCPS, provides an overview of hepatitis C, including some risk factors.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/vivid/pharmacytimes.jpg)
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2019-12-17_Practice_Pearls_Hepatitis_C_Preview.jpg)
Peter Salgo, MD will lead a panel of experts to identify the new, curative treatment options for hepatitis C, and restrictions to access.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2019-12-17_2C65511E-8E58-4913-A390-8DDE3F5B323C_1_100_o.jpeg)
The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2019-12-08_Hepatitis_Virus.jpg)
The study evaluated lymphoma characteristics and outcomes in hepatitis C virus-associated B-cell non-Hodgkin lymphoma in African American patients.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/uploadedmedia/images/2019-10-18_Hepatitis_Virus.jpg)
Chronic hepatitis B virus (HBV), which affects an estimated 862,000 individuals in the United States, is caused by long-term infection with the virus and can lead to serious liver damage.